Yan Zhou Selected Research

1-methylhydantoin

6/2019

Antitussive and Anti-inflammatory Dual-active Agents Developed from Natural Product Lead Compound 1-Methylhydantoin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yan Zhou Research Topics

Disease

307	Neoplasms (Cancer) 10/2022 - 01/2003
101	Infections 02/2022 - 07/2003
75	Inflammation (Inflammations) 07/2022 - 08/2007
54	Neoplasm Metastasis (Metastasis) 01/2022 - 12/2008
46	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2005
42	Hepatocellular Carcinoma (Hepatoma) 04/2022 - 09/2007
40	Stomach Neoplasms (Stomach Cancer) 12/2021 - 12/2006
32	Carcinogenesis 04/2022 - 04/2007
30	Carcinoma (Carcinomatosis) 01/2022 - 03/2003
28	Alzheimer Disease (Alzheimer's Disease) 05/2021 - 03/2002
26	Fibrosis (Cirrhosis) 04/2022 - 12/2003
21	Glioma (Gliomas) 11/2021 - 12/2002
19	Colorectal Neoplasms (Colorectal Cancer) 03/2022 - 01/2011
19	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 02/2007
18	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2021 - 01/2011
17	COVID-19 08/2022 - 01/2020
17	Hypoxia (Hypoxemia) 01/2022 - 01/2005
16	Cognitive Dysfunction 01/2022 - 08/2009
16	Virus Diseases (Viral Diseases) 01/2022 - 04/2005
15	Body Weight (Weight, Body) 05/2022 - 10/2005
15	Necrosis 01/2022 - 01/2005
14	Pulmonary Fibrosis (Fibrosing Alveolitis) 06/2022 - 01/2007
14	Hypertension (High Blood Pressure) 02/2022 - 05/2004
13	Osteosarcoma (Osteogenic Sarcoma) 01/2022 - 05/2011
13	Human Influenza (Influenza) 02/2021 - 12/2007
12	Hemorrhage 07/2022 - 06/2002
12	Lung Neoplasms (Lung Cancer) 04/2022 - 01/2010
12	Wounds and Injuries (Trauma) 10/2021 - 04/2011
11	Obesity 06/2022 - 04/2005
11	Pancreatic Neoplasms (Pancreatic Cancer) 02/2022 - 12/2005
11	Nasopharyngeal Carcinoma 01/2022 - 07/2013
11	Mitochondrial Diseases (Mitochondrial Disease) 01/2022 - 03/2009
11	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 01/2014
11	Ovarian Neoplasms (Ovarian Cancer) 01/2020 - 11/2005
10	Lymphoma (Lymphomas) 01/2022 - 01/2005
10	Stroke (Strokes) 01/2022 - 01/2013
10	Diarrhea 01/2022 - 09/2013
10	Leukemia 01/2021 - 05/2003
10	Parkinson Disease (Parkinson's Disease) 01/2021 - 08/2011
10	Uveomeningoencephalitic Syndrome (Vogt Koyanagi Harada Syndrome) 03/2015 - 08/2012
9	Osteoarthritis 07/2022 - 09/2015
9	Cardiovascular Diseases (Cardiovascular Disease) 06/2022 - 08/2002
9	Alcoholism (Alcohol Abuse) 01/2022 - 01/2012
9	Fever (Fevers) 01/2022 - 01/2005
9	Pain (Aches) 01/2022 - 06/2013
9	Neuroinflammatory Diseases 01/2022 - 08/2007
8	Asthma (Bronchial Asthma) 06/2022 - 05/2008

Drug/Important Bio-Agent (IBA)

120	Proteins (Proteins, Gene)FDA Link 06/2022 - 06/2002
67	Biomarkers (Surrogate Marker)IBA 09/2022 - 01/2010
49	Pharmaceutical PreparationsIBA 02/2022 - 09/2003
44	CytokinesIBA 01/2022 - 01/2005
40	MicroRNAs (MicroRNA)IBA 01/2022 - 12/2011
38	Biological ProductsIBA 09/2022 - 08/2007
38	Messenger RNA (mRNA)IBA 11/2021 - 06/2002
34	RNA (Ribonucleic Acid)IBA 05/2022 - 07/2006
28	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 09/2003
26	VaccinesIBA 01/2022 - 05/2005
24	Long Noncoding RNAIBA 03/2022 - 01/2012
20	Glucose (Dextrose)FDA LinkGeneric 09/2022 - 12/2003
18	Phosphotransferases (Kinase)IBA 04/2022 - 12/2002
17	AntibodiesIBA 01/2022 - 10/2009
17	Therapeutic UsesIBA 01/2022 - 11/2008
17	CollagenIBA 01/2022 - 10/2004
16	LipidsIBA 05/2022 - 05/2008
16	EnzymesIBA 04/2022 - 01/2002
16	Small Interfering RNA (siRNA)IBA 04/2022 - 11/2005
16	Antiviral Agents (Antivirals)IBA 04/2021 - 10/2012
15	LigandsIBA 01/2022 - 04/2002
15	AntigensIBA 01/2022 - 09/2007
14	Interleukin-6 (Interleukin 6)IBA 07/2022 - 01/2005
13	sulforaphaneIBA 10/2021 - 01/2014
12	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 09/2003
12	Caspase 3 (Caspase-3)IBA 11/2021 - 04/2011
12	InterleukinsIBA 10/2021 - 03/2014
12	ErbB Receptors (EGF Receptor)IBA 07/2021 - 06/2007
11	LipopolysaccharidesIBA 07/2022 - 11/2008
11	Cisplatin (Platino)FDA LinkGeneric 07/2022 - 07/2011
11	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2022 - 04/2002
11	Cysteine (L-Cysteine)FDA Link 01/2021 - 09/2016
10	CateninsIBA 06/2022 - 11/2012
10	Bleomycin (Blenoxane)FDA LinkGeneric 06/2022 - 01/2007
10	CholesterolIBA 02/2022 - 04/2005
10	ChemokinesIBA 11/2020 - 12/2002
10	Antineoplastic Agents (Antineoplastics)IBA 01/2018 - 05/2003
9	InflammasomesIBA 01/2022 - 04/2016
9	NF-kappa B (NF-kB)IBA 08/2021 - 01/2005
9	Interleukin-10 (Interleukin 10)IBA 01/2021 - 04/2011
9	Estrogens (Estrogen)FDA Link 01/2021 - 01/2004
9	Amyloid (Amyloid Fibrils)IBA 03/2019 - 07/2003
8	BerberineIBA 07/2022 - 04/2013
8	Transcription Factors (Transcription Factor)IBA 06/2022 - 06/2003
8	Glutamic Acid (Glutamate)FDA Link 06/2022 - 02/2009
8	Blood Glucose (Blood Sugar)IBA 05/2022 - 06/2012
8	Immune Checkpoint InhibitorsIBA 04/2022 - 01/2020

Therapy/Procedure

132	Therapeutics 04/2022 - 05/2002
45	Drug Therapy (Chemotherapy) 07/2022 - 04/2010
17	Transplantation 06/2022 - 04/2010
17	Radiotherapy 01/2022 - 01/2012
12	Aftercare (After-Treatment) 01/2022 - 05/2011
9	Immunotherapy 01/2022 - 05/2011